Buscar
Mostrando ítems 1-10 de 29
Selective Mastoparan inhibition of muscarinic activation of bovine tracheal smooth muscle
(AVFT Archivos Venezolanos de Farmacología y Terapéutica, 2013)
Evidence of a Ca(2+)-(center dot)NO-cGMP signaling pathway controlling zoospore biogenesis in the aquatic fungus Blastocladiella emersonii
(ACADEMIC PRESS INC ELSEVIER SCIENCE, 2009)
The sporulation stage of the aquatic fungus Blastocladiella emersonii culminates with the formation and release to the medium of a number of zoospores, which are motile cells responsible for the dispersal of the fungus. ...
Nitric oxide sensitive-guanylyl cyclase subunits expression changes during estrous cycle in anterior pituitary glands
(American Physiological Society, 2009-04)
17β-Estradiol (E2) exerts inhibitory actions on the nitric oxide pathway in rat adult pituitary glands. Previously, we reported that in vivo E2 acute treatment had opposite effects on soluble guanylyl cyclase (sGC) subunits, ...
Soluble guanylyl cyclase alpha1 subunit: a new marker for estrogenicity of endocrine disruptor compounds
(Society of Environmental Toxicology and Chemistry, 2019-09)
Endocrine disruptor compounds (EDCs) comprise naturally occurring and synthetic substances widely spread in the environment that adversely affect human and wildlife. Because of the increasing number of EDCs, screening ...
Treatment With Metformin Improves Erectile Dysfunction In A Murine Model Of Obesity Associated With Insulin Resistance
(ELSEVIER SCIENCE INCNEW YORK, 2015)
The role of superoxide anion in the inhibitory effect of SIN-1 in thrombin-activated human platelet adhesion
(Elsevier Science BvAmsterdamHolanda, 2010)
Soluble Guanylyl Cyclase (sgc) Degradation And Impairment Of Nitric Oxide-mediated Responses In Urethra From Obese Mice: Reversal By The Sgc Activator Bay 60-2770
(American Society for Pharmacology and Experimental Therapy, 2014)
Molecular mechanisms underlying rat mesenteric artery vasorelaxation induced by the nitric oxide-independent soluble guanylyl cyclase stimulators BAY 41-2272 [5-cyclopropyl-2-[1-(2-fluorobenzyl)-1H- pyrazolo[3,4-b]pyridin-3yl]pyrimidin-4-ylamine] and YC-1 [3-(5 '- hydroxymethyl-2 '-furyl)-1-benzyl indazole]
(Amer Soc Pharmacology Experimental TherapeuticsBethesdaEUA, 2006)